Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction

References

• JemalAWardEMJohnsonCJAnnual report to the nation on the status of cancer, 1975–2014, featuring survivalJ Natl Cancer Inst20171099122
   Google Scholar
• MomekovGFerdinandovDBakalovaAZaharievaMKonstantinovSKaraivanovaMIn vitro toxicological evaluation of a dinuclear platinum(II) complex with acetate ligandsArch Toxicol200680955556016485120
   PubMed Web of Science ®Google Scholar
• JungYLippardSJDirect cellular responses to platinum-induced DNA damageChem Rev200710751387140717455916
   PubMed Web of Science ®Google Scholar
• WuZMuJWangQHydroxyl and amino functionalized cyclometalated Ir(III) complexes: synthesis, characterization and cytotoxicity studiesJ Organomet Chem2015791175182
   Web of Science ®Google Scholar
• LiuZSalassaLHabtemariamAPizarroAMClarksonGJSadlerPJContrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium (III) complexesInorg Chem201150125777578321618978
   PubMed Web of Science ®Google Scholar
• HisamatsuYShibuyaASuzukiNDesign and synthesis of amphiphilic and luminescent triscyclometalated iridium(III) complexes containing cationic peptides as inducers and detectors of cell death via a calcium-dependent pathwayBioconjug Chem201526585787925875312
   PubMed Web of Science ®Google Scholar
• YouYNamWPhotofunctional triplet excited states of cyclometalated Ir(III) complexes: beyond electroluminescenceChem Soc Rev201241217061708422797418
   PubMed Web of Science ®Google Scholar
• TangBWanDWangYJYiQYGuoBHLiuYJAn iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathwayEur J Med Chem201814530231429331753
   PubMed Web of Science ®Google Scholar
• HartMAcottSPhysical and chemical stability of Taxotere (docetaxel) one-vial (20 mg/ml) infusion solution following refrigerated storageEcancermedicalscience2010420222276044
   PubMedGoogle Scholar
• WeiszhárZCzúczJRévészCRosivallLSzebeniJRozsnyayZComplement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20Eur J Pharm Sci201245449249821963457
   PubMed Web of Science ®Google Scholar
• van ZuylenLVerweijJSparreboomARole of formulation vehicles in taxane pharmacologyInvest New Drugs200119212514111392447
   PubMed Web of Science ®Google Scholar
• ChildKJCurrieJPDisBThe pharmacological properties in animals of CT1341–a new steroid anaesthetic agentBr J Anaesth19714312134251319
   PubMed Web of Science ®Google Scholar
• DoebeliAMichelEBettschartRHartnackSReichlerIMApgar score after induction of anesthesia for canine cesarean section with alfaxalone versus propofolTheriogenology201380885085423932170
   PubMed Web of Science ®Google Scholar
• QuWZuoWLiNDesign of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical applicationJ Drug Target201725866167228438041
   PubMed Web of Science ®Google Scholar
• JoneALiposomes: a short reviewJ Pharm Sci Res201359181183
   Google Scholar
• KolateABaradiaDPatilSVhoraIKoreGMisraAPEG – a versatile conjugating ligand for drugs and drug delivery systemsJ Control Release2014192678124997275
   PubMed Web of Science ®Google Scholar
• KohliAGKiersteadPHVendittoVJWalshCLSzokaFCDesigner lipids for drug delivery: from heads to tailsJ Control Release201419027428724816069
   PubMed Web of Science ®Google Scholar
• AllenTMThe use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte systemAdv Drug Del Rev1994133285309
   Web of Science ®Google Scholar
• ImmordinoMLDosioFCattelLStealth liposomes: review of the basic science, rationale, and clinical applications existing and potentialInt J Nanomedicine20061329731517717971
   PubMed Web of Science ®Google Scholar
• ZhangCLaiSHZengCCThe induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complexJ Biol Inorg Chem20162181047106027796592
   PubMed Web of Science ®Google Scholar
• HuangSLMacDonaldRCAcoustically active liposomes for drug encapsulation and ultrasound-triggered releaseBiochim Biophys Acta200416651–213414115471579
   PubMed Web of Science ®Google Scholar
• SeeEZhangWLiuJPhysicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionizationInt J Pharm20144731–252853525079434
   PubMed Web of Science ®Google Scholar
• XiongHDuSNiJZhouJYaoJMitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicinBiomaterials201694708327105438
   PubMed Web of Science ®Google Scholar
• CaoZCuiYNguyenHMJenkinsDPWulffHPessahINNanomolar bifenthrin alters synchronous Ca2+ oscillations and cortical neuron development independent of sodium channel activityMol Pharmacol201485463063924482397
   PubMed Web of Science ®Google Scholar
• GregoriadisGLeathwoodPDRymanBEEnzyme entrapment in liposomesFEBS Lett1971142959911945728
   PubMed Web of Science ®Google Scholar
• BhattacharjeeSDLS and zeta potential – what they are and what they are not?J Control Release201623533735127297779
   PubMed Web of Science ®Google Scholar
• TreuelLEslahianKADocterDPhysicochemical characterization of nanoparticles and their behavior in the biological environmentPhys Chem Chem Phys20141629150531506724943742
   PubMed Web of Science ®Google Scholar
• XiangBJiaXLQiJLEnhancing sirNa-based cancer therapy using a new ph-responsive activatable cell-penetrating peptide-modified liposomal systemInt J Nanomedicine2017122385240528405163
   PubMed Web of Science ®Google Scholar
• KouchakzadehHShojaosadatiSAMaghsoudiAVasheghani FarahaniEOptimization of PEGylation conditions for BSA nanoparticles using response surface methodologyAAPS PharmSciTech20101131206121120680708
   PubMed Web of Science ®Google Scholar
• ShenJKimHCWolframJA liposome encapsulated ruthenium polypyridine complex as a theranostic platform for triple-negative breast cancerNano Lett20171752913292028418672
   PubMed Web of Science ®Google Scholar
• SmithRAHartleyRCCocheméHMMurphyMPMitochondrial pharmacologyTrends Pharmacol Sci201233634135222521106
   PubMed Web of Science ®Google Scholar
• SmithRAHartleyRCMurphyMPMitochondria-targeted small molecule therapeutics and probesAntioxid Redox Signal201115123021303821395490
   PubMed Web of Science ®Google Scholar
• ZielonkaJJosephJSikoraAMitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applicationsChem Rev201711715100431012028654243
   PubMed Web of Science ®Google Scholar
• LiSDongPWangJIcariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK- dependent mitochondrial pathwayCancer Lett2010298222223020674153
   PubMed Web of Science ®Google Scholar
• PyleAMRehmannJPMeshoyrerRMixed-ligand complexes of ruthenium(II): factors governing binding to DNAJ Am Chem Soc1989111830513058
   Web of Science ®Google Scholar
• WronaMPatelKWardmanPReactivity of 2′,7′-dichlorodihydrofluorescein and dihydrorhodamine 123 and their oxidized forms toward carbonate, nitrogen dioxide, and hydroxyl radicalsFree Radic Biol Med200538226227015607909
   PubMed Web of Science ®Google Scholar
• ZhivotovskyBOrreniusSCalcium and cell death mechanisms: a perspective from the cell death communityCell Calcium201150321122121459443
   PubMed Web of Science ®Google Scholar
• PrevarskayaNOuadid-AhidouchHSkrymaRShubaYRemodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?Philos Trans R Soc Lond B Biol Sci201436916382013009724493745
   PubMed Web of Science ®Google Scholar
• FarsinejadSGheisaryZEbrahimi SamaniSMitochondrial targeted peptides for cancer therapyTumor Biol201536857155725
   PubMedGoogle Scholar
• ShapiroGIHarperJWAnticancer drug targets: cell cycle and checkpoint controlJ Clin Invest1999104121645165310606615
   PubMed Web of Science ®Google Scholar